<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=136091"><dc:title>Serum bilirubin levels in overweight and obese individuals</dc:title><dc:creator>Žiberna,	Lovro	(Avtor)
	</dc:creator><dc:creator>Jenko Pražnikar,	Zala	(Avtor)
	</dc:creator><dc:creator>Petelin,	Ana	(Avtor)
	</dc:creator><dc:subject>adipokines</dc:subject><dc:subject>antioxidant</dc:subject><dc:subject>anti-inflammatory</dc:subject><dc:subject>bilirubin</dc:subject><dc:subject>obesity</dc:subject><dc:subject>overweight</dc:subject><dc:description>Obesity is a chronic condition involving low-grade inflammation and increased oxidative stress; thus, obese and overweight people have lower values of serum bilirubin. Essentially, bilirubin is a potent endogenous antioxidant molecule with anti-inflammatory, immunomodulatory, antithrombotic, and endocrine properties. This review paper presents the interplay betweeen obesity-related pathological processes and bilirubin, with a focus on adipose tissue and adipokines. We discuss potential strategies to mildly increase serum bilirubin levels in obese patients as an adjunctive therapeutic approach.</dc:description><dc:date>2021</dc:date><dc:date>2022-04-12 12:34:55</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>136091</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
